益气活血化瘀方治疗高血压性脑基底节出血术后的临床研究Clinical Observation of Yiqi Huoxue Huayu Decoction on Hypertensive Cerebral Basal Ganglia Hemorrhage After Operation
于召虎,潘源,孟令占,辛涛,卢佩林
摘要(Abstract):
目的观察益气活血化瘀方治疗高血压性脑基底节出血术后的临床疗效。方法将60例高血压性脑基底节出血患者随机分为观察组28例与对照组32例,对照组予单纯手术治疗,观察组在手术基础上联合益气活血化瘀方治疗。观察两组患者在治疗前后格拉斯哥昏迷指数(GCS)评分、肌力、血肿体积、中医证候积分、住院时间,并评估疗效。结果经治疗后,两组患者GCS评分明显下降,血肿体积明显缩小,中医证候积分明显降低,术后瘫痪侧肌力均明显改善(均P <0.05),观察组改善程度优于对照组(P <0.05);观察组中医证候总有效率为75.00%,明显高于对照组的59.38%(P <0.05);观察组的住院时间明显短于对照组(P <0.05)。结论益气活血化瘀方联合手术治疗可明显改善高血压性脑基底节出血患者的GCS评分、肌力,降低中医证候积分,缩小血肿体积,缩短住院时间,提高中医证候疗效。
关键词(KeyWords): 脑基底节出血;高血压;益气活血化瘀方
基金项目(Foundation): 重庆市中医药科技项目(ZY20150231)
作者(Author): 于召虎,潘源,孟令占,辛涛,卢佩林
参考文献(References):
- [1] Mould WA,Carhuapoma JR,Muschelli J,et al. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema[J]. Stroke,2013,44(3):627-634.
- [2]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南(2019)[J].中华神经科杂志,2019,52(12):994-1005.
- [3] van Asch CJ,Luitse MJ,Rinkel GJ,et al. Incidence,case fatality,and functional outcome of intracerebral haemorrhage over time,according to age,sex,and ethnic origin:a systematic review and meta-analysis[J]. Lancet Neurol,2010,9(2):167-176.
- [4]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑血管疾病分类2015[J].中华神经科杂志,2017:50(3):168-171.
- [5] Morgenstern LB,Hemphill JC,3rd,Anderson C,et al. Guidelines for the management of spontaneous intracerebral hemorrhage:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2010,41(9):2108-2129.
- [6] Hemphill JC,3rd,Greenberg SM,Anderson CS,et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J].Stroke,2015,46(7):2032-2060.
- [7] Qureshi AI,Palesch YY,Barsan WG,et al. Intensive bloodpressure lowering in patients with acute cerebral hemorrhage[J]. N Engl J Med,2016,375(11):1033-1043.
- [8]王忠诚.王忠诚神经外科学[M]. 2版.武汉:湖北科学技术出版社,2005:366-406.
- [9]中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国中医药科技出版社,2002:26.
- [10] Zhang HT,Xue S,Li PJ,et al. Treatment of huge hypertensive putaminal hemorrhage by surgery and cerebrospinal fluid drainage[J]. Clinical neurology and neurosurgery,2013,115(9):1602-1608.
- [11] Gotoh S,Hata J,Ninomiya T,et al. Trends in the incidence and survival of intracerebral hemorrhage by its location in a Japanese community[J]. Circ J,2014,78(2):403-409.
- [12] Choo YS,Chung J,Joo JY,et al. Borderline basal ganglia hemorrhage volume:patient selection for good clinical outcome after stereotactic catheter drainage[J]. J Neurosurg,2016,125(5):1242-1248.
- [13] Urday S,Kimberly WT,Beslow LA,et al. Targeting secondary injury in intracerebral haemorrhage-perihaematomal oedema[J]. Nat Rev Neurol,2015,11(2):111-122.
- [14]孙霄,陶英群,金海,等. ROSA与立体定向框架辅助手术治疗高血压脑出血的对比研究[J].中华神经外科杂志,2018,34(7):674-677.
- [15]王超,游潮,刘窗溪,等.高血压脑出血后血浆及脑脊液IL-1β和IL-6在病情评估中的应用价值[J].中华神经外科杂志,2015,31(11):1158-1160.
- [16]孙传河,廖伟龙,高鹏琳,等.高血压性脑出血后二次脑损伤的发病机制及中西医防治进展[J].神经病学与神经康复学杂志,2016,12(4):215-220.
- [17]丘晟,陈淑雯,阎仁福,等.微创治疗对基底核区出血患者血肿周围水肿及皮质脊髓束的影响[J].中华神经外科杂志,2018,34(11):1148-1151.
- [18] Lee JG,Lee SH,Park DW,et al. Phosphatidic acid as a regulator of matrix metalloproteinase-9 expression via the TNFalpha signaling pathway[J]. Febs Let,2007,581(4):787-793.
- [19] Du Z,Liu J,Jia H,et al. The brain cytokine levels are modulated by estrogen following traumatic brain injury:Which estrogen receptor serves as modulator[J]. Int Immunopharmacol,2015,28(1):279-287.
- [20]张长福,谭占国,袁波,等.基底节区高血压性脑出血的临床治疗经验[J].中华神经外科杂志,2017,33(12):1266-1267.